vs
西铁城（CIA）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是西铁城的1.0倍（$75.5M vs $72.1M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 13.5%），西铁城自由现金流更多（$17.5M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 11.7%）
西铁城钟表株式会社，又称西铁城集团，是总部位于日本东京西东京市的知名跨国电子企业，核心业务为腕表制造，是西铁城集团的核心企业。除西铁城品牌腕表外，集团还拥有美国钟表公司宝路华，业务同时涵盖计算器、打印机、医疗设备与精密CNC加工设备制造。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CIA vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.0倍
$72.1M
营收增速更快
PBYI
高出14.2%
13.5%
自由现金流更多
CIA
多$3.2M
$14.4M
两年增速更快
PBYI
近两年复合增速
11.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $72.1M | $75.5M |
| 净利润 | $7.3M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 10.9% | 22.7% |
| 净利率 | 10.2% | — |
| 营收同比 | 13.5% | 27.7% |
| 净利润同比 | 102.7% | — |
| 每股收益（稀释后） | — | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CIAPBYI
| Q4 25 | $72.1M | $75.5M | ||
| Q3 25 | $62.8M | $54.5M | ||
| Q2 25 | $65.1M | $52.4M | ||
| Q1 25 | $55.7M | $46.0M | ||
| Q4 24 | $63.5M | $59.1M | ||
| Q3 24 | $61.7M | $80.5M | ||
| Q2 24 | $62.1M | $47.1M | ||
| Q1 24 | $57.7M | $43.8M |
净利润CIAPBYI
| Q4 25 | $7.3M | — | ||
| Q3 25 | $2.4M | $8.8M | ||
| Q2 25 | $6.5M | $5.9M | ||
| Q1 25 | $-1.6M | $3.0M | ||
| Q4 24 | $3.6M | — | ||
| Q3 24 | $2.8M | $20.3M | ||
| Q2 24 | $4.0M | $-4.5M | ||
| Q1 24 | $4.5M | $-4.8M |
毛利率CIAPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率CIAPBYI
| Q4 25 | 10.9% | 22.7% | ||
| Q3 25 | 7.1% | 17.6% | ||
| Q2 25 | 10.6% | 12.7% | ||
| Q1 25 | -3.2% | 8.7% | ||
| Q4 24 | 5.9% | 22.6% | ||
| Q3 24 | 4.9% | 27.4% | ||
| Q2 24 | 5.3% | -4.6% | ||
| Q1 24 | 8.5% | -5.3% |
净利率CIAPBYI
| Q4 25 | 10.2% | — | ||
| Q3 25 | 3.8% | 16.2% | ||
| Q2 25 | 9.9% | 11.2% | ||
| Q1 25 | -2.9% | 6.5% | ||
| Q4 24 | 5.7% | — | ||
| Q3 24 | 4.5% | 25.2% | ||
| Q2 24 | 6.4% | -9.6% | ||
| Q1 24 | 7.9% | -11.0% |
每股收益（稀释后）CIAPBYI
| Q4 25 | — | $0.26 | ||
| Q3 25 | — | $0.17 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | — | $0.41 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.0M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $235.0M | $130.3M |
| 总资产 | $1.8B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CIAPBYI
| Q4 25 | $23.0M | $97.5M | ||
| Q3 25 | $23.1M | $94.4M | ||
| Q2 25 | $22.7M | $96.0M | ||
| Q1 25 | $18.4M | $93.2M | ||
| Q4 24 | $29.3M | $101.0M | ||
| Q3 24 | $32.4M | $96.7M | ||
| Q2 24 | $26.3M | $96.8M | ||
| Q1 24 | $23.2M | $107.2M |
总债务CIAPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益CIAPBYI
| Q4 25 | $235.0M | $130.3M | ||
| Q3 25 | $225.6M | $115.3M | ||
| Q2 25 | $229.0M | $104.7M | ||
| Q1 25 | $218.1M | $97.1M | ||
| Q4 24 | $210.4M | $92.1M | ||
| Q3 24 | $207.6M | $71.1M | ||
| Q2 24 | $191.5M | $48.5M | ||
| Q1 24 | $195.2M | $51.0M |
总资产CIAPBYI
| Q4 25 | $1.8B | $216.3M | ||
| Q3 25 | $1.7B | $202.9M | ||
| Q2 25 | $1.7B | $194.9M | ||
| Q1 25 | $1.7B | $196.2M | ||
| Q4 24 | $1.7B | $213.3M | ||
| Q3 24 | $1.7B | $220.7M | ||
| Q2 24 | $1.7B | $205.0M | ||
| Q1 24 | $1.7B | $214.1M |
负债/权益比CIAPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.0M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $17.5M | $14.4M |
| 自由现金流率自由现金流/营收 | 24.3% | 19.1% |
| 资本支出强度资本支出/营收 | 0.6% | 0.0% |
| 现金转化率经营现金流/净利润 | 2.45× | — |
| 过去12个月自由现金流最近4个季度 | $26.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流CIAPBYI
| Q4 25 | $18.0M | $14.4M | ||
| Q3 25 | $4.7M | $9.7M | ||
| Q2 25 | $3.5M | $14.1M | ||
| Q1 25 | $748.0K | $3.6M | ||
| Q4 24 | $31.9M | $15.6M | ||
| Q3 24 | $9.7M | $11.0M | ||
| Q2 24 | $4.6M | $1.0M | ||
| Q1 24 | $6.8M | $11.2M |
自由现金流CIAPBYI
| Q4 25 | $17.5M | $14.4M | ||
| Q3 25 | $4.6M | $9.7M | ||
| Q2 25 | $3.3M | $14.1M | ||
| Q1 25 | $641.0K | $3.6M | ||
| Q4 24 | $31.3M | $15.6M | ||
| Q3 24 | $9.3M | $11.0M | ||
| Q2 24 | $4.5M | $1.0M | ||
| Q1 24 | $6.7M | — |
自由现金流率CIAPBYI
| Q4 25 | 24.3% | 19.1% | ||
| Q3 25 | 7.3% | 17.7% | ||
| Q2 25 | 5.1% | 26.8% | ||
| Q1 25 | 1.2% | 7.7% | ||
| Q4 24 | 49.2% | 26.4% | ||
| Q3 24 | 15.1% | 13.7% | ||
| Q2 24 | 7.2% | 2.1% | ||
| Q1 24 | 11.7% | — |
资本支出强度CIAPBYI
| Q4 25 | 0.6% | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 0.3% | 0.0% | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | 1.0% | 0.0% | ||
| Q3 24 | 0.6% | 0.0% | ||
| Q2 24 | 0.2% | 0.0% | ||
| Q1 24 | 0.1% | 0.0% |
现金转化率CIAPBYI
| Q4 25 | 2.45× | — | ||
| Q3 25 | 1.93× | 1.10× | ||
| Q2 25 | 0.54× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | 8.81× | — | ||
| Q3 24 | 3.48× | 0.54× | ||
| Q2 24 | 1.16× | — | ||
| Q1 24 | 1.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
